Topic: Biomarker analyses and association with clinical outcomes in patients

Biomarker analyses and association with clinical outcomes in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib with or without erlotinib in the phase III SEARCH trial.

Not specifically CC related but know that some are on sorafenib so thought I'd post it anyway.

http://abstracts.asco.org/144/AbstView_144_130930.html

Any advice or comments I give are based on personal experiences and knowledge and are my opinions only, they are not to be substituted for professional medical advice. Please seek professional advice from a qualified doctor or medical professional.